Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial.
Vinereanu D, Lopes RD, Bahit MC, Xavier D, Jiang J, Al-Khalidi HR, He W, Xian Y, Ciobanu AO, Kamath DY, Fox KA, Rao MP, Pokorney SD, Berwanger O, Tajer C, de Barros E Silva PGM, Roettig ML, Huo Y, Granger CB; IMPACT-AF investigators. Vinereanu D, et al. Among authors: berwanger o. Lancet. 2017 Oct 14;390(10104):1737-1746. doi: 10.1016/S0140-6736(17)32165-7. Epub 2017 Aug 28. Lancet. 2017. PMID: 28859942 Clinical Trial.
A multifaceted intervention to narrow the evidence-based gap in the treatment of acute coronary syndromes: rationale and design of the Brazilian Intervention to Increase Evidence Usage in Acute Coronary Syndromes (BRIDGE-ACS) cluster-randomized trial.
Berwanger O, Guimarães HP, Laranjeira LN, Cavalcanti AB, Kodama A, Zazula AD, Santucci E, Victor E, Flato UA, Tenuta M, Carvalho V, Mira VL, Pieper KS, Mota LH, Peterson ED, Lopes RD; BRIDGE-ACS. Berwanger O, et al. Am Heart J. 2012 Mar;163(3):323-29, 329.e1. doi: 10.1016/j.ahj.2012.02.004. Am Heart J. 2012. PMID: 22424001 Free article. Clinical Trial.
Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil.
Lopes RD, Becker RC, Newby LK, Peterson ED, Hylek EM, Granger CB, Crowther M, Wang T, Carvalho AC, Berwanger O, Giraldez RR, Feitosa GS, Ribeiro JP, Darze E, Kalil RA, Andrande M, Boas FV, Andrade J, Rocha AT, Harrington RA, Lopes AC, Garcia DA. Lopes RD, et al. Among authors: berwanger o. J Thromb Thrombolysis. 2012 Jul;34(1):143-63. doi: 10.1007/s11239-012-0700-3. J Thromb Thrombolysis. 2012. PMID: 22427055
Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: the BRIDGE-ACS randomized trial.
Berwanger O, Guimarães HP, Laranjeira LN, Cavalcanti AB, Kodama AA, Zazula AD, Santucci EV, Victor E, Tenuta M, Carvalho V, Mira VL, Pieper KS, Weber B, Mota LH, Peterson ED, Lopes RD; Bridge-Acs Investigators. Berwanger O, et al. JAMA. 2012 May 16;307(19):2041-9. doi: 10.1001/jama.2012.413. JAMA. 2012. PMID: 22665103 Clinical Trial.
Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, Brazil.
Lopes RD, Becker RC, Newby LK, Peterson ED, Hylek EM, Giugliano R, Granger CB, Mahaffey KW, Carvalho AC, Berwanger O, Giraldez RR, Feitosa-Filho GS, Barbosa MM, da Consolacao V Moreira M, Kalil RA, Freitas M, de Campos Guerra JC, Barros MV, da Rocha Rodrigues T, Lopes AC, Garcia DA. Lopes RD, et al. Among authors: berwanger o. J Thromb Thrombolysis. 2013 Jul;36(1):115-30. doi: 10.1007/s11239-013-0906-z. J Thromb Thrombolysis. 2013. PMID: 23494487
Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: insights from the ClinicalTrials.gov registry.
Bernardez-Pereira S, Lopes RD, Carrion MJ, Santucci EV, Soares RM, de Oliveira Abreu M, Laranjeira LN, Ikeoka DT, Zazula AD, Moreira FR, Cavalcanti AB, Mesquita ET, Peterson ED, Califf RM, Berwanger O; Methodological Evaluation of clinical TriAls Study Group. Bernardez-Pereira S, et al. Among authors: berwanger o. Am Heart J. 2014 Aug;168(2):213-9.e1. doi: 10.1016/j.ahj.2014.04.013. Epub 2014 May 2. Am Heart J. 2014. PMID: 25066561
Rationale and design of the First Brazilian Cardiovascular Registry of Atrial Fibrillation: The RECALL study.
Lopes RD, de Paola AA, Lorga Filho AM, Consolim-Colombo FM, Andrade J, Piva E Mattos LA, Bernardez-Pereira S, Berwanger O, de Oliveira Figueiredo MJ; RECALL Steering Committee and Investigators. Lopes RD, et al. Among authors: berwanger o. Am Heart J. 2016 Jun;176:10-6. doi: 10.1016/j.ahj.2016.03.001. Epub 2016 Mar 8. Am Heart J. 2016. PMID: 27264215
A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale.
Rao MP, Ciobanu AO, Lopes RD, Fox KA, Xian Y, Pokorney SD, Al-Khalidi HR, Jiang J, Kamath DY, Berwanger O, Xavier D, Bahit CM, Tajer C, Vinereanu D, Huo Y, Granger CB. Rao MP, et al. Among authors: berwanger o. Am Heart J. 2016 Jun;176:107-13. doi: 10.1016/j.ahj.2016.03.011. Epub 2016 Mar 21. Am Heart J. 2016. PMID: 27264227 Clinical Trial.
Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial.
Berwanger O, de Barros E Silva PG, Barbosa RR, Precoma DB, Figueiredo EL, Hajjar LA, Kruel CD, Alboim C, Almeida AP, Dracoulakis MD, Filho HV, Carmona MJ, Maia LN, de Oliveira Filho JB, Saraiva JF, Soares RM, Damiani L, Paisani D, Kodama AA, Gonzales B, Ikeoka DT, Devereaux PJ, Lopes RD; LOAD Investigators. Berwanger O, et al. Am Heart J. 2017 Feb;184:88-96. doi: 10.1016/j.ahj.2016.11.001. Epub 2016 Nov 9. Am Heart J. 2017. PMID: 27892891 Clinical Trial.
209 results